---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-000075"
form_type: "8-K"
ticker: "PMN"
cik: "0001374339"
company_name: "ProMIS Neurosciences Inc."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T06:25:03.009032+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ProMIS Neurosciences receives Nasdaq minimum bid price deficiency notice; has until July 2, 2025 to regain compliance

## Summary
- Received Nasdaq notice on Jan 3, 2025 for failing $1 minimum bid price rule for 30 consecutive trading days.
- Has 180 calendar days (until July 2, 2025) to regain compliance by closing bid price >= $1 for 10 consecutive days.
- If not compliant, may be eligible for an additional 180-day period if meets other listing standards and provides intention to cure.
- Company will consider options to regain compliance but no assurance of success; shares continue trading under PMN.

## SEC filing metadata
- accession: 0001558370-25-000075
- form_type: 8-K
- ticker: PMN
- cik: 0001374339
- company_name: ProMIS Neurosciences Inc.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374339/000155837025000075/0001558370-25-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374339/000155837025000075/pmn-20250103x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-000075
- JSON: https://secwatch.observer/filing/0001558370-25-000075.json
- Plain text: https://secwatch.observer/filing/0001558370-25-000075.txt

## Key facts
- Listing & Compliance Notices
  ProMIS Neurosciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: January 3, 2025, ProMIS Neurosciences Inc. (“Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s common shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1374339/000155837025000075/0001558370-25-000075-index.htm
- Listing & Compliance Notices
  ProMIS Neurosciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: January 3, 2025, ProMIS Neurosciences Inc. (“Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company’s common shares, no par value (the “Common Shares”) failed to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) based upon the closing bid price of the Common Shares for the 30 consecutive trading days prior to the date of the Minimum Bid Price Notice from Nasdaq. The Notice has n
  evidence_url: https://www.sec.gov/Archives/edgar/data/1374339/000155837025000075/0001558370-25-000075-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.